GRETA SKAGEN: Open Payments
NPI 1396350898 · CHEYENNE, WY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$769 in 33 payments from 22 companies in 2025. Trend: 2023 $1,109 · 2024 $1,241 · 2025 $769
Food & beverage: $769
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 4 | $96 |
| Merck Sharp & Dohme LLC | 3 | $68 |
| E.R. Squibb & Sons, L.L.C. | 2 | $58 |
| Daiichi Sankyo Inc. | 2 | $57 |
| Incyte Corporation | 2 | $50 |
| Novartis Pharmaceuticals Corporation | 2 | $43 |
| AstraZeneca Pharmaceuticals LP | 2 | $41 |
| PFIZER INC. | 2 | $33 |
| Aveo Pharmaceuticals, Inc. | 1 | $33 |
| Genmab U.S., Inc. | 1 | $30 |
Products named: KEYTRUDA, OPDIVO, Enhertu, RYBREVANT, IMFINZI, FOTIVDA, Tivdak, LONSURF.
Industry payments across WY — which companies pay providers there.
